JPH0541707Y2 - - Google Patents
Info
- Publication number
- JPH0541707Y2 JPH0541707Y2 JP2169191U JP2169191U JPH0541707Y2 JP H0541707 Y2 JPH0541707 Y2 JP H0541707Y2 JP 2169191 U JP2169191 U JP 2169191U JP 2169191 U JP2169191 U JP 2169191U JP H0541707 Y2 JPH0541707 Y2 JP H0541707Y2
- Authority
- JP
- Japan
- Prior art keywords
- tube
- drug
- present
- powdered
- ulcer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 claims description 53
- 229940079593 drug Drugs 0.000 claims description 37
- 238000002347 injection Methods 0.000 claims description 11
- 239000007924 injection Substances 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 11
- 208000025865 Ulcer Diseases 0.000 description 12
- 231100000397 ulcer Toxicity 0.000 description 12
- 230000003902 lesion Effects 0.000 description 9
- 239000007789 gas Substances 0.000 description 8
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 235000010413 sodium alginate Nutrition 0.000 description 7
- 229940005550 sodium alginate Drugs 0.000 description 7
- 239000000661 sodium alginate Substances 0.000 description 7
- 230000000740 bleeding effect Effects 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 208000008469 Peptic Ulcer Diseases 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 239000003699 antiulcer agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000000718 duodenal ulcer Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- IVVHAAOJLULJLK-YDXSIYMFSA-E Aceglutamide aluminum Chemical compound [OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Al+3].CC(=O)N[C@H](C([O-])=O)CCC(N)=O.CC(=O)N[C@H](C([O-])=O)CCC(N)=O.CC(=O)N[C@H](C([O-])=O)CCC(N)=O.CC(=O)N[C@H](C([O-])=O)CCC(N)=O.CC(=O)N[C@H](C([O-])=O)CCC(N)=O IVVHAAOJLULJLK-YDXSIYMFSA-E 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 206010027146 Melanoderma Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229930192392 Mitomycin Natural products 0.000 description 1
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960002627 aceglutamide aluminum Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- FHRSHSOEWXUORL-HDJSIYSDSA-N cetraxate Chemical compound C1C[C@@H](C[NH3+])CC[C@@H]1C(=O)OC1=CC=C(CCC([O-])=O)C=C1 FHRSHSOEWXUORL-HDJSIYSDSA-N 0.000 description 1
- 229950009533 cetraxate Drugs 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 1
- 229960002908 cimetidine hydrochloride Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- -1 suralfate Chemical compound 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- WFWLQNSHRPWKFK-ZCFIWIBFSA-N tegafur Chemical compound O=C1NC(=O)C(F)=CN1[C@@H]1OCCC1 WFWLQNSHRPWKFK-ZCFIWIBFSA-N 0.000 description 1
- 229960001674 tegafur Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2169191U JPH0541707Y2 (en:Method) | 1991-04-04 | 1991-04-04 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2169191U JPH0541707Y2 (en:Method) | 1991-04-04 | 1991-04-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0488953U JPH0488953U (en:Method) | 1992-08-03 |
| JPH0541707Y2 true JPH0541707Y2 (en:Method) | 1993-10-21 |
Family
ID=31756631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2169191U Expired - Lifetime JPH0541707Y2 (en:Method) | 1991-04-04 | 1991-04-04 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0541707Y2 (en:Method) |
-
1991
- 1991-04-04 JP JP2169191U patent/JPH0541707Y2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0488953U (en:Method) | 1992-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020108787A (ja) | 消化管感染症に対する管腔内治療システム | |
| TW201321006A (zh) | 用於瘻管之治療的組成物 | |
| CZ278497A3 (cs) | Způsob a sestava zařízení k prevenci impotence | |
| US5591445A (en) | Smooth muscle chemical pacemaker | |
| CN208809293U (zh) | 一种消化内科食道涂药器 | |
| JP2017164514A (ja) | 再調製デバイス | |
| CN107224663A (zh) | 一种新型泌尿外科用尿道给药器 | |
| JPH0541707Y2 (en:Method) | ||
| CN205667564U (zh) | 一种肛肠止血海绵 | |
| CN1303717A (zh) | 经皮给药仪 | |
| Bray et al. | Treatment of canine nasal aspergillosis with a new non‐invasive technique. Failure with enilconazole | |
| CN207085061U (zh) | 一种粉剂妇科给药器 | |
| HU221675B1 (hu) | Hatóanyaghordozó hatóanyagok szabályzott felszabadítására a gyomor-bélcsatornában, késleltetett gyomorkapu-passzázs útján | |
| JPS58188464A (ja) | 粉末薬剤局所投与方法および装置 | |
| WO2015023479A1 (en) | Devices and systems anchored in the gastrointestinal tract | |
| RU2253449C1 (ru) | Способ эрадикации инфекции helicobacter pylori в желудке | |
| Meleney | Present role of zinc peroxide in treatment of surgical infections | |
| CN201076663Y (zh) | 非自反气管导管 | |
| Winfield | Routes of administration and dosage forms | |
| Kusano et al. | Initiation of esophageal secondary peristalsis by slow fluid infusion in the opossum: effect of hydrochloric acid | |
| CN213248912U (zh) | 一种消化道出血护理装置 | |
| CN219764267U (zh) | 一种粉末液体两用内镜下给药装置 | |
| CN109907723A (zh) | 一种消化内科用送药装置 | |
| CN213642777U (zh) | 一种肛肠外科给药装置 | |
| CN101920063A (zh) | 腔道黏膜给药器、给药装置和给药方法 |